Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Molecular Interaction of Collagen with Cell Receptors for Biological Function. | Polymers (Basel) | 2022 | 35267698 | PubTator, text mining | PubMed |
| Corrigendum to "comparative exome sequencing reveals novel candidate genes for retinitis pigmentosa" [EBioMedicine 56(2020)102792] DOI: https://doi.org/10.1016/j.ebiom.2020.102792. | EBioMedicine | 2022 | 35248995 | PubTator, text mining | PubMed |
| Colorectal liver metastasis: molecular mechanism and interventional therapy. | Signal Transduct Target Ther | 2022 | 35246503 | PubTator, text mining | PubMed |
| Identification of potential microRNA groups for the diagnosis of hepatocellular carcinoma (HCC) using microarray datasets and bioinformatics tools. | Heliyon | 2022 | 35243101 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor 1, a Potential Biomarker and Therapeutic Target in Hepatocellular Carcinoma. | Int J Gen Med | 2022 | 35237068 | PubTator, text mining | PubMed |
| Molecular and Cellular Mechanisms Underlying the Initiation and Progression of Alport Glomerular Pathology. | Front Med (Lausanne) | 2022 | 35223933 | PubTator, text mining | PubMed |
| MicroRNA-199b Deregulation Shows Oncogenic Properties and Promising Clinical Value as Circulating Marker in Locally Advanced Rectal Cancer Patients. | Int J Mol Sci | 2022 | 35216319 | PubTator, text mining | PubMed |
| Integration of Transcriptome and Exome Genotyping Identifies Significant Variants with Autism Spectrum Disorder. | Pharmaceuticals (Basel) | 2022 | 35215271 | PubTator, text mining | PubMed |
| Evaluation of the Expression of miR-486-3p, miR-548-3p, miR-561-5p and miR-509-5p in Tumor Biopsies of Patients with Oral Squamous Cell Carcinoma. | Pathogens | 2022 | 35215154 | PubTator, text mining | PubMed |
| Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies. | Cancers (Basel) | 2022 | 35205760 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor 1 Expression in Colon Cancer: Roles and Prognosis Impact. | Cancers (Basel) | 2022 | 35205677 | PubTator, text mining | PubMed |
| Emerging Therapeutic Strategies for Parkinson's Disease and Future Prospects: A 2021 Update. | Biomedicines | 2022 | 35203580 | PubTator, text mining | PubMed |
| Human bronchial epithelial cells from patients with asthma have an altered gene expression profile. | ERJ Open Res | 2022 | 35198626 | PubTator, text mining | PubMed |
| Surgical procedures and innovative approaches for vitiligo regenerative treatment and melanocytorrhagy. | J Dermatol | 2022 | 35178747 | PubTator, text mining | PubMed |
| Circular RNA circ_0068464 combined with microRNA-383 regulates Wnt/β-catenin pathway to promote the progression of colorectal cancer. | Bioengineered | 2022 | 35168468 | PubTator, text mining | PubMed |
| Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas. | Cells | 2022 | 35159370 | PubTator, text mining | PubMed |
| TSPAN1-elevated FAM110A promotes pancreatic cancer progression by transcriptionally regulating HIST1H2BK. | J Cancer | 2022 | 35154458 | PubTator, text mining | PubMed |
| Transmembrane 4 L Six Family Member 1 Suppresses Hormone Receptor--Positive, HER2-Negative Breast Cancer Cell Proliferation. | Front Pharmacol | 2022 | 35153775 | PubTator, text mining | PubMed |
| DDR1 associates with TRPV4 in cell-matrix adhesions to enable calcium-regulated myosin activity and collagen compaction. | J Cell Physiol | 2022 | 35150133 | PubTator, text mining | PubMed |
| DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6. | Oncogene | 2022 | 35140331 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=37